Thank you for Subscribing to CIO Applications Weekly Brief

ERT Launches Data Insights to Optimize Study Efficiency
ERT (eResearch Technology) is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence.
By
CIO Applications | Sunday, December 27, 2020

ERT (eResearch Technology) is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence.
FREMONT, CA: ERT, a leading global data and technology company, which minimizes risk and uncertainty in clinical trials, announced the launch of Data Insights, its newest Trial Oversight solution. Designed to more accurately and rapidly discover variabilities in endpoint data collection and management, Data Insights empowers study teams to take proactive action to protect their data's validity and integrity and keep their study on track and on time.
ERT's Data Insights removes the burden of spotting data variabilities from study managers and teams through advanced diagnostic, predictive, and prescriptive analytics. It features a configurable dashboard that enables trial managers to weight metrics and customize notifications and suggested actions based on data quality thresholds. Additionally, Data Insights provides a centralized and detailed view of ERT's clinical and operational data across portfolios and individual studies, allows for granular data review, and generates issue-specific reports with study, site, and metric-specific details. The resulting focus on high-value activity and shared insight help to reduce and target remediation effort, improve team decision-making, and increase trust in data quality and compliance overall.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
"Data variability often requires study teams invest significant time and effort to uncover and understand problematic data and contributes to the reality that so few clinical studies end on time," said Dr. Otis Johnson, vice president of Trial Oversight. "Data Insights serves as an early indicator system, identifying studies at greater compliance or quality risk and highlighting the specific issue so our customers and users can spend less time investigating problems and more time solving them."
In addition to configurable tracking and event notification, Data Insights customers and users receive 24/7 Multilingual Customer Care and the ability to sort data into the portfolio, study, and site-specific views. Data Insights is part of ERT's robust collection of Data Analytics offerings, including ERT's Business Intelligence suite and Data Exchange.
Check This Out: Studies Weekly | Education Technology Insights
More in News

